Cadila Pharmaceuticals recognized among Top 20 Corporates Committed to Viksit Bharat. This esteemed recognition comes from the distinguished SKOCH Group.
Ahmedabad: Cadila Pharmaceuticals, a pioneering force in innovation and one of India’s premier privately held pharmaceutical companies, has proudly earned its place among the Top 20 Corporates Committed to Viksit Bharat.
This esteemed recognition comes from the distinguished SKOCH Group, a leading consulting firm renowned for its comprehensive services spanning strategy consulting, policy advocacy, alliances, research, conventions, CSR, and more, through their prestigious “India Involved Assessment – 2023.“
In this assessment, Cadila Pharmaceuticals stands shoulder to shoulder with India’s foremost corporations dedicated to propelling the nation towards the vision of a developed India, championed by Prime Minister Shri. Narendra Modi. This acknowledgment underscores Cadila Pharmaceuticals’ unwavering commitment to fostering sustainable growth and inclusive development.
The selection criteria for this prestigious roster encompassed various critical parameters, including digital transformation, environmental stewardship, governance, and corporate excellence. Furthermore, SKOCH Group meticulously evaluated each company’s initiatives aimed at tackling societal challenges such as healthcare accessibility, employment generation, skill enhancement, and gender parity. The India Involved Assessment represents a pivotal initiative in aligning corporate endeavors with national development objectives and addressing societal disparities.
Cadila Pharmaceuticals Ltd. is one of India’s leading integrated privately held pharmaceutical firms, located in Ahmedabad, Gujarat. The firm develops and produces pharmaceutical products in India and sells and distributes them in over 100 countries. The organization places a high emphasis and priority on research, whether it is in biotechnology, APIs, formulations, plant tissue culture or phytochemistry to innovate in various therapeutic areas including gastrointestinal, cardiology, pulmonary, oncology, gynaecology, cardiovascular, Diabetology, and osteology. Its undaunted commitment to create affordable miracles in therapeutic areas with significant unmet medical needs to serve the society & community at large, has led to several world-first breakthroughs.
